Physician profile
Joseph Mileti
NPI 1003826546
$16,708.43
in general payments reported to CMS, 2019-2025
10 companies · $748 in 2025
The $748 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $359 · 2021: $2,929 · 2022: $5,030 · 2023: $6,219 · 2024: $1,116 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,360 · Food and Beverage: $1,326 · Travel and Lodging: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,360.00 |
| Food and Beverage | $1,325.68 |
| Travel and Lodging | $397.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,859.07 | 2021-2025 | Aequalis Perform, Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $2,910.60 | 2019-2023 | Comprehensive Shoulder System, Identity, Juggerknotless Soft Anchor |
| Cdc Medical LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $753.09 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame |
| Becton, Dickinson and Company | $293.23 | 2022 | |
| Wright Medical Technology, INC. | $278.97 | 2019-2020 | |
| Arthrex, INC. | $208.00 | 2023 | |
| Djo, LLC | $100.00 | 2019 | |
| Cosa Medical, LLC | $70.05 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $35.42 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mileti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.